SCHEMBL23040906

SCHEMBL23040906

C[CH]C(=O)NCCN(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.44
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA12 O43570 1/20 0.43
CA9 Q16790 1/20 0.43
KDM4E B2RXH2 2/20 0.43
HTT P42858 3/20 0.42
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.39
MAPK1 P28482 1/20 0.39
PRMT3 O60678 1/20 0.39
CARM1 Q86X55 1/20 0.39
PRMT6 Q96LA8 1/20 0.39
PRMT1 Q99873 1/20 0.39
PRMT8 Q9NR22 1/20 0.39
USP2 O75604 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL108355 0.83 DNM1 (0.42) DNM1CA1CA2CA12CA9
SCHEMBL11436694 0.83 DNM1 (0.42) DNM1CA1CA2CA12CA9
SCHEMBL14562554 0.82 KDM4E (0.47) DNM1CA1CA2CA12CA9
SCHEMBL27346 0.80 ALDH1A1 (0.56) DNM1CA1CA2CA12CA9
SCHEMBL2654857 0.80 DNM1 (0.43) DNM1CA1CA2CA12CA9
Hydrochloric Acid SCHEMBL2804444 0.78 ALDH1A1 (0.54) DNM1CA1CA2CA12CA9
Chloromethane SCHEMBL1099332 0.77 ALDH1A1 (0.52) DNM1CA1CA2CA12CA9
SCHEMBL19669933 0.77 ALDH1A1 (0.46) DNM1CA1CA2CA12CA9
SCHEMBL15600779 0.77 ALDH1A1 (0.42) DNM1CA1CA2CA12CA9
SCHEMBL27339834 0.77 ALDH1A1 (0.59) DNM1KDM4EALDH1A1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11084842-B2 Glucopyranosyl derivative and use thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2021-08-10 US disclosed
US-20210061839-A1 GLUCOPYRANOSYL DERIVATIVE AND USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2021-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210061839-A1 GLUCOPYRANOSYL DERIVATIVE AND USE THEREOF SLC5A1, SLC5A2, UGGT1 DNM1 2343/4885CA1 3420/4885CA2 977/4885
US-11084842-B2 Glucopyranosyl derivative and use thereof SLC5A1, SLC5A2, UGGT1 DNM1 2343/4885CA1 3420/4885CA2 977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.